How accurate is in vitro prediction of carcinogenicity?
Open Access
- 22 February 2011
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 162 (6), 1250-1258
- https://doi.org/10.1111/j.1476-5381.2010.01131.x
Abstract
Positive genetic toxicity data suggest carcinogenic hazard, and this can stop a candidate pharmaceutical reaching the clinic. However, during the last decade, it has become clear that many non-carcinogens produce misleading positive results in one or other of the regulatory genotoxicity assays. These doubtful conclusions cost a lot of time and money, as they trigger additional testing of apparently genotoxic candidates, both in vitro and in animals, to discover whether the suggested hazard is genuine. This in turn means that clinical trials can be put on hold. This review describes the current approaches to the 'misleading positive' problem as well as efforts to reduce the use of animals in genotoxicity assessment. The following issues are then addressed: the application of genotoxicity testing screens earlier in development; the search for new or improved in vitro genotoxicity tests; proposed changes to the International Committee on Harmonisation guidance on genotoxicity testing [S2(R1)]. Together, developments in all these areas offer good prospects of a more rapid and cost-effective way to understand genetic toxicity concerns.Keywords
This publication has 52 references indexed in Scilit:
- International Conference on Harmonisation; guidance on S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals intended for Human Use; availability. Notice.2012
- New and emerging technologies for genetic toxicity testingEnvironmental and Molecular Mutagenesis, 2010
- Comparison of the Ames II and traditional Ames test responses with respect to mutagenicity, strain specificities, need for metabolism and correlation with rodent carcinogenicityMutagenesis, 2009
- Intralaboratory and interlaboratory evaluation of the EpiDerm™ 3D human reconstructed skin micronucleus (RSMN) assayMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2009
- DNA intercalative potential of marketed drugs testing positive in in vitro cytogenetics assaysMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2006
- Recommendations for conducting the in vivo alkaline Comet assayMutagenesis, 2003
- A review of the genotoxicity of marketed pharmaceuticalsMutation Research - Reviews in Mutation Research, 2001
- Simple and reliable enumeration of micronucleated reticulocytes with a single-laser flow cytometerMutation Research/Genetic Toxicology, 1996
- Validation of the SOS/umu test using test results of 486 chemicals and comparison with the Ames test and carcinogenicity dataMutation Research/Genetic Toxicology, 1996
- p53, guardian of the genomeNature, 1992